1,938 results on '"MacKensen, Andreas"'
Search Results
2. Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome
3. CAR-T-Zell-Therapie in der Rheumatologie – Was wissen wir bisher?
4. CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial
5. The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of Germany
6. Adoptive transfer of donor B lymphocytes: a phase 1/2a study for patients after allogeneic stem cell transplantation
7. Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee
8. Targeted inhibition of protein synthesis renders cancer cells vulnerable to apoptosis by unfolded protein response
9. CAR T-cell therapy in autoimmune diseases
10. A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS.
11. Climate forcing of regional deep-sea biodiversity documented by benthic foraminifera
12. Identification and characterization of T-cell receptors with therapeutic potential showing conserved specificity against all SARS-CoV 2 strains
13. Author Correction: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
14. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
15. Liver-FDG-uptake and CAR T-cell kinetics augment early PET/CT prognostic value for CD19-targeted CAR T-cell therapy in diffuse large B cell lymphoma
16. Selective CAR-T cell mediated B cell depletion suppresses interferon signature in SLE
17. Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8/A9high AML cell subset
18. Fully Human Anti-CD19 CAR T Cells Derived from Systemic Lupus Erythematosus Patients Exhibit Cytotoxicity with Reduced Inflammatory Cytokine Production
19. The metabolic profile of reconstituting T-cells, NK-cells, and monocytes following autologous stem cell transplantation and its impact on outcome
20. Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
21. CAR T-cell therapy rescues adolescent with rapidly progressive lupus nephritis from haemodialysis
22. The WERA Cancer Center Matrix: Strategic Management of Patient Access to Precision Oncology in a Large and Mostly Rural Area of Germany
23. Detection of signature double‐negative T cells is a predictive marker to identify autoimmune lymphoproliferative syndrome associated with FAS loss of function
24. Increased PD-1 Expression on Circulating T Cells Correlates with Inferior Outcome after Autologous Stem Cell Transplantation
25. CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
26. Upper ocean variability off NE Greenland (79°N) since the last glacial maximum reconstructed from stable isotopes in planktic foraminifer morphotypes
27. Calibration of the carbon isotope composition (δ13C) of benthic foraminifera
28. Late Quaternary climatic variability in northern Patagonia, Argentina, based on δ18O of modern and fossil shells of Amiantis purpurata (Bivalvia, Veneridae)
29. Impact of Nrf2 expression in reconstituting T-cells of allogeneic hematopoietic stem cell transplanted patients
30. CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus Erythematosus
31. Comment on: Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T-cells after failure of several B cell depleting antibodies: reply
32. Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center
33. Cytokine and reactivity profiles in SLE patients following anti-CD19 CART therapy
34. Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL
35. Two cases of carfilzomib‐induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma
36. Stable carbon isotopes in paleoceanography: atmosphere, oceans, and sediments
37. Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial
38. Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
39. Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma
40. Age and Growth of Olivancillaria deshayesiana (Gastropoda: Olividae) in the Southwestern Atlantic Ocean
41. Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study
42. Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion
43. Anatomy of a glacial meltwater discharge event in an Antarctic cove
44. Late Holocene Ameghinomya antiqua shells from the Beagle Channel: A multi-proxy approach to palaeoenvironmental and palaeoclimatic reconstruction
45. Chaperone protein HSC70 regulates intercellular transfer of Y chromosome antigen DBY
46. A novel immunoregulatory function of beta-2-microglobulin as a promoter of myeloid derived suppressor cell induction
47. Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway
48. Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use
49. Case Report: IBD-like colitis following CAR T cell therapy for diffuse large B cell lymphoma
50. Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.